AOD-9604 5mg Peptides
Serious research starts with precise, consistent materials you can trust.
Better Molecule AOD-9604 is supplied as a lyophilized research peptide in a sealed vial, providing 5mg per unit for controlled laboratory work. This presentation supports standardized handling and reliable preparation, aligning with disciplined research practices and modern quality expectations.
- Each vial contains 5mg of AOD-9604, a growth hormone fragment peptide frequently investigated for its role in metabolic signaling pathways, adipose tissue research, and peptide stability and formulation studies.
Developed for laboratory environments, this lyophilized format allows measured reconstitution according to protocol, supporting consistent aliquoting, accurate dilution planning, and repeatable assay design. The compact, single-vial presentation aids in inventory control and minimizes unnecessary exposure during routine bench procedures.
Researchers value uniformity and clarity at every step, from receipt to data collection. This vial is prepared to meet those expectations—organized, straightforward, and ready for integration into existing workflows. Whether configuring in vitro assays, preparing reference standards, or exploring method development, AOD-9604 in this format is designed to help maintain procedural consistency across runs and between teams.
Quality and verification: Better Molecule emphasizes controlled manufacturing, careful handling, and rigorous lot-level testing to confirm identity and assess purity. Each batch is reviewed using validated analytical methods, and documentation is maintained to support traceability and lab compliance needs. A Certificate of Analysis is available to qualified purchasers upon request.
Trusted sourcing: Better Molecule is a USA-based provider focused on research-use compounds, with standards that prioritize precision, transparency, and dependable supply. Our processes are built around lab-first requirements—clear labeling, thoughtful presentation, and reliable specifications—so researchers can proceed with confidence.
For laboratory research use only. Not for human consumption, veterinary use, or diagnostic or therapeutic applications. Handle with appropriate laboratory PPE and in accordance with institutional protocols. Reconstitution, storage conditions, and disposal should follow your lab’s SOPs and applicable regulations.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
- 1
- 2
- 3
- 4
- 5
Reviews (1)
AOD-9604 5mg Peptides
Frequently Asked Questions
What is AOD-9604?
AOD-9604 is a modified fragment of human growth hormone, commonly described as the 176-191 region. In research settings it is presented as a peptide of interest in lipid-metabolism studies, with a profile intended to differ from full-length growth hormone. It should be framed as a research compound only.
What is AOD-9604 typically studied for?
AOD-9604 is most often studied in relation to fat metabolism, lipolysis, and body-weight regulation in experimental models. It is usually distinguished from full HGH by the fact that researchers investigate it for metabolic effects without assuming the broader growth-promoting actions of native growth hormone.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Better Molecule are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
